Cargando…

Correction: Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months

Detalles Bibliográficos
Autores principales:	Peng, Pai, Hu, Jie, Deng, Hai-jun, Liu, Bei-zhong, Fang, Liang, Wang, Kai, Tang, Ni, Huang, Ai-long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427092/ https://www.ncbi.nlm.nih.gov/pubmed/36042353 http://dx.doi.org/10.1038/s41423-022-00915-9

Ejemplares similares

Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
por: Peng, Pai, et al.
Publicado: (2021)

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
por: Hu, Jie, et al.
Publicado: (2021)

Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine
por: Peng, Pai, et al.
Publicado: (2021)

Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months
por: Zheng, Yang, et al.
Publicado: (2021)

Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera
por: Hu, Jie, et al.
Publicado: (2021)

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
por: Anand, Sai Priya, et al.
Publicado: (2021)

Correction: SARS-CoV-2-specific immune response in COVID-19 convalescent individuals
por: Pan, Yunbao, et al.
Publicado: (2021)

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
por: Ni, Ling, et al.
Publicado: (2020)

Maintenance of neutralizing antibodies over ten months in convalescent SARS‐CoV‐2 afflicted patients
por: Sonnleitner, Sissy Therese, et al.
Publicado: (2021)

Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
por: Li, Cesheng, et al.
Publicado: (2021)

Correction to: Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection
por: Fodor, Eszter, et al.
Publicado: (2022)

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2020)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection
por: Miyakawa, Kei, et al.
Publicado: (2021)

Humoral Response in SARS-CoV-2 Convalescent Compared to Vaccinated Kidney Transplant Patients
por: Schimpf, Judith, et al.
Publicado: (2022)

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
por: Zabalza, Ana, et al.
Publicado: (2022)

SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV()
por: Giannone, Denise, et al.
Publicado: (2022)

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
por: Garcia-Beltran, Wilfredo F., et al.
Publicado: (2021)

Correction: A pre-vaccine exploratory survey of SARS-CoV-2 humoral immunity among Egyptian general population
por: El-Ghitany, Engy Mohamed, et al.
Publicado: (2022)

Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
por: Butler, Savannah E., et al.
Publicado: (2021)

SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
por: Wu, Jun, et al.
Publicado: (2021)

Acquisition of Humoral Immune Responses in Convalescent Japanese People with SARS-CoV-2 (COVID-19) Infection in 2021
por: Monzen, Koshiro, et al.
Publicado: (2023)

Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
por: Paniskaki, Krystallenia, et al.
Publicado: (2023)

Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
por: Glück, Vivian, et al.
Publicado: (2022)

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection
por: Sherina, Natalia, et al.
Publicado: (2021)

Publisher Correction: Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population
por: Carrat, Fabrice, et al.
Publicado: (2022)

Correction to: Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
Publicado: (2022)

SARS‐CoV‐2‐specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma
por: Lindemann, Monika, et al.
Publicado: (2021)

SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
por: Geers, Daryl, et al.
Publicado: (2021)

Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19
por: Hocini, Hakim, et al.
Publicado: (2023)

HUMORAL ANTIBODIES AND RESISTANCE OF VACCINATED AND CONVALESCENT MONKEYS TO POLIOMYELITIS VIRUS
por: Sabin, Albert B., et al.
Publicado: (1936)

Humoral and cellular response in convalescent COVID-19 lupus patients
por: Solé, Cristina, et al.
Publicado: (2022)

SARS-CoV-2-specific T cell responses wane profoundly in convalescent individuals 10 months after primary infection
por: Li, Ziwei, et al.
Publicado: (2023)

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial
por: Eckhardt, Christina M., et al.
Publicado: (2020)

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial
por: Eckhardt, Christina M., et al.
Publicado: (2020)

A 1-year longitudinal study on COVID-19 convalescents reveals persistence of anti-SARS-CoV-2 humoral and cellular immunity
por: Li, Yang, et al.
Publicado: (2022)

Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
por: Barouch, Dan H., et al.
Publicado: (2021)

Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines
por: Gil-Manso, Sergio, et al.
Publicado: (2022)

Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
por: Zuo, Jianmin, et al.
Publicado: (2021)

Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents
por: Li, Zhiqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o39ugo96stfccd7rpe9sajr3mh